Skip to main content

Inducing Long-Term HIV-1 Latency in the TKO-BLT Mouse Model

  • Protocol
  • First Online:
HIV Reservoirs

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2407))

Abstract

Multiple humanized mouse models have been produced for the study of HIV-1 infection and treatment. Humanized mice produced using the bone marrow, liver, thymus (BLT) method particularly have well-reconstituted and functional human immune systems, providing an excellent model for HIV-1 cure strategies that aim to harness the human immune system as part of the cure approach. The TKO-BLT humanized mouse model is especially useful for long-term studies as it is highly resistant to the wasting syndrome and graft-versus-host disease (GVHD ) that can limit the use of other BLT-models. Here we describe the methods used to induce latency in TKO-BLT mice, using both injectable and free-fed combination antiretroviral therapy (cART) regimens, for use in the study of HIV-1 latency and evaluation of HIV-1 cure interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Choudhary SK, Archin NM, Cheema M, Dahl NP, Garcia JV, Margolis DM (2012) Latent HIV-1 infection of resting CD4(+) T cells in the humanized Rag2(−)/(−) gammac(−)/(−) mouse. J Virol 86(1):114–120. https://doi.org/10.1128/JVI.05590-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Choudhary SK, Rezk NL, Ince WL, Cheema M, Zhang L, Su L, Swanstrom R, Kashuba AD, Margolis DM (2009) Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2−/−{gamma}c−/− mouse. J Virol 83(16):8254–8258. https://doi.org/10.1128/JVI.00580-09

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sango K, Joseph A, Patel M, Osiecki K, Dutta M, Goldstein H (2010) Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2−/−gammac−/− mice. AIDS Res Hum Retrovir 26(7):735–746. https://doi.org/10.1089/aid.2009.0136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Denton PW, Olesen R, Choudhary SK, Archin NM, Wahl A, Swanson MD, Chateau M, Nochi T, Krisko JF, Spagnuolo RA, Margolis DM, Garcia JV (2012) Generation of HIV latency in humanized BLT mice. J Virol 86(1):630–634. https://doi.org/10.1128/JVI.06120-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Marsden MD, Kovochich M, Suree N, Shimizu S, Mehta R, Cortado R, Bristol G, An DS, Zack JA (2012) HIV latency in the humanized BLT mouse. J Virol 86(1):339–347. https://doi.org/10.1128/JVI.06366-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Nischang M, Sutmuller R, Gers-Huber G, Audige A, Li D, Rochat MA, Baenziger S, Hofer U, Schlaepfer E, Regenass S, Amssoms K, Stoops B, Van Cauwenberge A, Boden D, Kraus G, Speck RF (2012) Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1. PLoS One 7(6):e38853. https://doi.org/10.1371/journal.pone.0038853

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Honeycutt JB, Wahl A, Archin N, Choudhary S, Margolis D, Garcia JV (2013) HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model. Retrovirology 10:121. https://doi.org/10.1186/1742-4690-10-121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Honeycutt JB, Thayer WO, Baker CE, Ribeiro RM, Lada SM, Cao Y, Cleary RA, Hudgens MG, Richman DD, Garcia JV (2017) HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy. Nat Med 23(5):638–643. https://doi.org/10.1038/nm.4319

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sun Z, Denton PW, Estes JD, Othieno FA, Wei BL, Wege AK, Melkus MW, Padgett-Thomas A, Zupancic M, Haase AT, Garcia JV (2007) Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med 204(4):705–714. https://doi.org/10.1084/jem.20062411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin HS, Brooks SF, Knight HL, Eichbaum Q, Yang YG, Sykes M, Walker BD, Freeman GJ, Pillai S, Westmoreland SV, Brander C, Luster AD, Tager AM (2009) Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol 83(14):7305–7321. https://doi.org/10.1128/JVI.02207-08

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lan P, Tonomura N, Shimizu A, Wang S, Yang YG (2006) Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 108(2):487–492. https://doi.org/10.1182/blood-2005-11-4388

    Article  CAS  PubMed  Google Scholar 

  12. Olesen R, Wahl A, Denton PW, Garcia JV (2011) Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection. J Reprod Immunol 88(2):195–203. https://doi.org/10.1016/j.jri.2010.11.005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Dudek TE, No DC, Seung E, Vrbanac VD, Fadda L, Bhoumik P, Boutwell CL, Power KA, Gladden AD, Battis L, Mellors EF, Tivey TR, Gao X, Altfeld M, Luster AD, Tager AM, Allen TM (2012) Rapid evolution of HIV-1 to functional CD8(+) T cell responses in humanized BLT mice. Sci Transl Med 4(143):143ra198. https://doi.org/10.1126/scitranslmed.3003984

    Article  CAS  Google Scholar 

  14. Lavender KJ, Pang WW, Messer RJ, Duley AK, Race B, Phillips K, Scott D, Peterson KE, Chan CK, Dittmer U, Dudek T, Allen TM, Weissman IL, Hasenkrug KJ (2013) BLT-humanized C57BL/6 Rag2−/−gammac−/-CD47−/− mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection. Blood 122(25):4013–4020. https://doi.org/10.1182/blood-2013-06-506949

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Greenblatt MB, Vrbanac V, Tivey T, Tsang K, Tager AM, Aliprantis AO (2012) Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. PLoS One 7(9):e44664. https://doi.org/10.1371/journal.pone.0044664

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lavender KJ, Pace C, Sutter K, Messer RJ, Pouncey DL, Cummins NW, Natesampillai S, Zheng J, Goldsmith J, Widera M, Van Dis ES, Phillips K, Race B, Dittmer U, Kukolj G, Hasenkrug KJ (2018) An advanced BLT-humanized mouse model for extended HIV-1 cure studies. AIDS 32(1):1–10. https://doi.org/10.1097/QAD.0000000000001674

    Article  CAS  PubMed  Google Scholar 

  17. Lavender KJ, Messer RJ, Race B, Hasenkrug KJ (2014) Production of bone marrow, liver, thymus (BLT) humanized mice on the C57BL/6 Rag2(−/−)gammac(−/−)CD47(−/−) background. J Immunol Methods 407:127–134. https://doi.org/10.1016/j.jim.2014.04.008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Llewellyn GN, Seclen E, Wietgrefe S, Liu S, Chateau M, Pei H, Perkey K, Marsden MD, Hinkley SJ, Paschon DE, Holmes MC, Zack JA, Louie SG, Haase AT, Cannon PM (2019) Humanized mouse model of HIV-1 latency with enrichment of latent virus in PD-1(+) and TIGIT(+) CD4 T cells. J Virol 93(10):e02086-18. https://doi.org/10.1128/JVI.02086-18

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tsai P, Wu G, Baker CE, Thayer WO, Spagnuolo RA, Sanchez R, Barrett S, Howell B, Margolis D, Hazuda DJ, Archin NM, Garcia JV (2016) In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection. Retrovirology 13(1):36. https://doi.org/10.1186/s12977-016-0268-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rochat MA, Schlaepfer E, Kuster SP, Li D, Audige A, Ivic S, Fahrny A, Speck RF (2018) Monitoring HIV DNA and cellular activation markers in HIV-infected humanized mice under cART. Virol J 15(1):191. https://doi.org/10.1186/s12985-018-1101-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Cheng L, Ma J, Li J, Li D, Li G, Li F, Zhang Q, Yu H, Yasui F, Ye C, Tsao LC, Hu Z, Su L, Zhang L (2017) Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest 127(1):269–279. https://doi.org/10.1172/JCI90745

    Article  PubMed  Google Scholar 

  22. Halper-Stromberg A, Lu CL, Klein F, Horwitz JA, Bournazos S, Nogueira L, Eisenreich TR, Liu C, Gazumyan A, Schaefer U, Furze RC, Seaman MS, Prinjha R, Tarakhovsky A, Ravetch JV, Nussenzweig MC (2014) Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell 158(5):989–999. https://doi.org/10.1016/j.cell.2014.07.043

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Malnati MS, Scarlatti G, Gatto F, Salvatori F, Cassina G, Rutigliano T, Volpi R, Lusso P (2008) A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load. Nat Protoc 3(7):1240–1248. https://doi.org/10.1038/nprot.2008.108

    Article  CAS  PubMed  Google Scholar 

  24. Butler SL, Hansen MS, Bushman FD (2001) A quantitative assay for HIV DNA integration in vivo. Nat Med 7(5):631–634. https://doi.org/10.1038/87979

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA and by the College of Medicine, University of Saskatchewan, Canada. The authors thank Daisy Alferez for assistance in editing the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kerry J. Lavender .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Di, Y., Lavender, K.J. (2022). Inducing Long-Term HIV-1 Latency in the TKO-BLT Mouse Model. In: Poli, G., Vicenzi, E., Romerio, F. (eds) HIV Reservoirs. Methods in Molecular Biology, vol 2407. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1871-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1871-4_18

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1870-7

  • Online ISBN: 978-1-0716-1871-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics